Browsing by Author Kim, Won-Seog
Showing results 1 to 2 of 2
| Issue Date | Title | Author(s) |
| Jan-2024 | Golidocitinib, a selective JAK1 tyrosine-kinase inhibitor, in patients with refractory or relapsed peripheral T-cell lymphoma (JACKPOTS Part B): a single-arm, multinational, phase 2 study | Song, Yuqin; Malpica, Luis; Cai, Qingqing; Zhao, Weili; Zhou, Keshu; Wu, Jianqiu; Zhang, Huilai; Mehta-Shah, Neha; Ding, Kaiyang; Liu, Yao; Li, Zengjun; Zhang, Liling; Zheng, Meifang; Jin, Jie; Yang, Haiyan; Shuang, Yuerong; Yoon, Dok Hyun; Gao, Sujun; Li, Wenyu; Zhai, Zhimin; Zou, Liqun; Xi, Yaming; Koh, Youngil; Li, Fei; Prince, Miles; Zhou, Hui; Lin, Lie; Liu, Hui; Allen, Pamela; Roncolato, Fernando; Yang, Zhenfan; Kim, Won-Seog; Zhu, Jun |
| 15-Nov-2022 | Preliminary Biomarker Data from a Phase 1/2 Study of Golidocitinib Demonstrates Targeting JAK/STAT Pathway to Treat Peripheral T-Cell Lymphoma | Song, Yuqin; Kim, Won-Seog; Yoon, Dok-Hyun; Yang, Haiyan; Cao, Junning; Ji, Dongmei; Koh, Youngil; Jing, Hongmei; Eom, Hyeon-Seok; Kwak, Jae-Yong; Lee, Won-Sik; Lee, Jong-Seok; Shin, Ho-Jin; Jin, Jie; Wang, Mei; Li, Jingrun; Zhu, Jun |
